1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 3:Intra-arterial chemotherapy for retinoblastoma in infants weighing ≤10 kg (74 treated eyes with 222 IAC sessions—weight, age, and number of previous successful attempts for infants of failed femoral access
Patient No. Weight (kg) Age (months) Previous Successful Attempts (n) 1 9.1 6.0 0 2 10.0 8.0 1 3 6.7 9.0 1 4 7.0 6.0 2 5 10.0 10.0 2 6 9.4 6.0 3